CD4 and HIV infectious disease: To examine whether the degree of immunosuppression, HIV‐infection status, or other unidentified underlying differences between Part A and Part B participants impacted clofazimine PK, baseline CD4 count, baseline HIV viral load, and study group assignment were assessed in the covariate selection process.